Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Mar 13;15(3):e0230694. doi: 10.1371/journal.pone.0230694

Correction: Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017

Lingyan Yu, Kai Ding, Lifang Luo, Zhenwei Yu
PMCID: PMC7069635  PMID: 32168367

There are a number of errors in the Year and Age values of Table 1. Please see the correct Table 1 here.

Table 1. The population demographic characteristics of included prescriptions from 2013 to 2017.

Year 2013 2014 2015 2016 2017
Age
18–39 1076 (7.79) 1196 (7.87) 1263 (7.90) 1648 (8.57) 1694 (8.44)
40–49 1134 (8.21) 1197 (7.88) 1304 (8.15) 1604(8.34) 1794 (8.94)
50–59 2324 (16.83) 2463 (16.20) 2439 (15.25) 3035 (15.78) 3139 (15.65)
60–69 3775 (27.34) 4156 (27.34) 4557(28.49) 5524 (28.72) 5828 (29.05)
70 up 5499 (39.82) 6188 (40.71) 6434 (40.22) 7421 (38.59) 7605 (37.91)
Sex
Male 8900 (46.12) 9677 (46.67) 9856 (45.85) 12408 (46.39) 12894 (45.84)
Female 10397 (53.88) 11057 (53.33) 11642 (54.15) 14342 (53.61) 15237 (54.16)

Data are represented as number of patients (%).

Reference

  • 1.Yu L, Ding K, Luo L, Yu Z (2020) Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017. PLoS ONE 15(1): e0227595 10.1371/journal.pone.0227595 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES